RE: Pharma stocks - clinical trials and MGC22 Feb 2021 23:55
Thanks Bmdjf, love the way its a big deal for their partners too not just mxc.
“This is a significant new product opportunity for Glow and our shareholders, as ArtemiC™ shows promising results that it may improve the clinical recovery of COVID-19 patients,“ said Rob Carducci, Chief Commercial Officer, Glow LifeTech Ltd. “We are extremely pleased that our MyCell™ Technology is helping to power a natural, safe and effective product that can be made widely accessible during these challenging times.”